AbSci nabs $10.4 mln Series D

Vancouver, Washington-based AbSci, a protein printing company, has closed $10.4 million in Series D financing.

Vancouver, Washington-based AbSci, a protein printing company, has closed $10.4 million in Series D financing. KBI Biopharma and JSR Life Sciences led the round.

Source: Press Release